Balanced news tone
News Sentiment
VLA sentiment intelligence
Valneva SE news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
47
Balanced news tone
17 relevant articles
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+0.8% over one week, -6.9% over four weeks, trend inactive, and below fair value.
Valneva Publishes Documentation for June 25, 2026 Annual General Meeting
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
85/100 classification
One-week reaction
0.8%
Price digesting
Trend fit
Trend inactive
-6.9% over four weeks
Fair value
-38.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
13
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
The Globe and Mail
Direct company coverage
Valneva Publishes Documentation for June 25, 2026 Annual General Meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 07:00
- Source
- The Globe and Mail
Stock Titan
Direct company coverage
Valneva (NASDAQ: VALN) details access to 2026 Annual General Meeting documents
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Valneva (NASDAQ: VALN) registers 31.8M shares, warrants tied to FDA milestone
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Valneva (NASDAQ: VALN) highlights Lyme vaccine and joins June investor events
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
€5.28: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
TradingView
Direct company coverage
Valneva SE Stock 12‑Month Price Target Cut to $12.98, Implies 116% Upside
- Tone
- Negative 35/100
- Event
- Analyst action
- Published
- 13 May 2026 07:00
- Source
- TradingView
marketscreener.com
Direct company coverage
French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 22 Apr 2026 07:00
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Valneva collapses following disappointing news on Lyme disease vaccine
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Mar 2026 07:00
- Source
- marketscreener.com
AD HOC NEWS
Direct company coverage
Valneva Shares Retreat Amid Technical Pressure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Feb 2026 08:00
- Source
- AD HOC NEWS
Capital.com
Direct company coverage
Valneva Stock Forecast 2026–2030 | Future Outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 13 Feb 2026 08:00
- Source
- Capital.com
simplywall.st
Direct company coverage
Is There Now an Opportunity in Valneva After Its 111% Surge in 2025?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Oct 2025 07:00
- Source
- simplywall.st
Reuters
Direct company coverage
Valneva shares tumble after suspension of US chikungunya vaccine licence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Aug 2025 07:00
- Source
- Reuters
marketscreener.com
Direct company coverage
Valneva: presentations planned at conferences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Nov 2024 08:00
- Source
- marketscreener.com
Reuters
Direct company coverage
Valneva guides for nearly double product sales by 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Mar 2024 07:00
- Source
- Reuters
Reuters
Direct company coverage
Valneva shares fall as French health body advises against its COVID-19 vaccine
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 08 Dec 2022 08:00
- Source
- Reuters
MarketWatch
Direct company coverage
Valneva shares spike after saying vaccine candidate outperformed AstraZeneca’s
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Oct 2021 07:00
- Source
- MarketWatch
Bloomberg.com
Direct company coverage
Valneva Plunges After U.K. Scraps Covid Vaccine Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Sep 2021 07:00
- Source
- Bloomberg.com